Thermo Fisher Scientific Inc. (TMO) EV/Assets Ratio: 1.98x
Is Thermo Fisher Scientific Inc.’s EV/Assets ratio high or low?
Thermo Fisher Scientific Inc.'s EV/Assets ratio of 1.98x is 23% below its 5-year average of 2.57x, near the low end of its 5-year range (1.80x–3.93x).
The EV/Assets ratio for Thermo Fisher Scientific Inc. (TMO) is 1.98x as of Tuesday, June 9, 2026. It is below its 12-month average by 8.13% (2.16x).
TMO EV/Assets Ratio Chart
TMO Average EV/Assets Ratio Chart
TMO Current vs Average EV/Assets Ratio Chart
TMO EV/Assets Ratio Metrics
EV/ASSETS RATIO
1.98x
EV/ASSETS RATIO AVG TTM
2.16x
EV/ASSETS RATIO AVG 3Y
2.33x
EV/ASSETS RATIO AVG 5Y
2.57x
EV/ASSETS RATIO AVG 10Y
2.40x
EV/ASSETS RATIO AVG 15Y
2.04x
EV/ASSETS RATIO AVG 20Y
1.82x
CURRENT VS TTM AVG
-8.13%
CURRENT VS 3Y AVG
-15.11%
CURRENT VS 5Y AVG
-23.03%
CURRENT VS 10Y AVG
-17.41%
CURRENT VS 15Y AVG
-3.17%
CURRENT VS 20Y AVG
+8.97%
TMO Competitors' EV/Assets Ratio
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (TMO) | — | 1.98x | 2.16x | 2.33x | 2.57x |
| Amgen Inc. (AMGN) | $185.96B | 2.52x | 2.46x | 2.26x | 2.38x |
| Abbott Laboratories (ABT) | $158.94B | 1.69x | 2.51x | 2.67x | 2.75x |
| Gilead Sciences, Inc. (GILD) | $155.82B | 3.05x | 3.05x | 2.43x | 2.15x |
| Intuitive Surgical, Inc. (ISRG) | $151.09B | 7.53x | 8.89x | 9.09x | 8.50x |
| Pfizer Inc. (PFE) | $146.48B | 1.01x | 1.00x | 1.03x | 1.28x |
| Danaher Corporation (DHR) | $133.37B | 1.76x | 1.98x | 2.16x | 2.26x |
| CVS Health Corporation (CVS) | $123.84B | 0.76x | 0.67x | 0.63x | 0.70x |
| Bristol-Myers Squibb Company (BMY) | $115.34B | 1.74x | 1.54x | 1.56x | 1.64x |
| Vertex Pharmaceuticals Incorporated (VRTX) | $113.14B | 4.18x | 4.45x | 4.69x | 4.46x |
Thermo Fisher Scientific Inc. EV/Assets Ratio Formula & Definition
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Thermo Fisher Scientific Inc. EV/Assets Ratio FAQ
- What is the EV/Assets ratio for Thermo Fisher Scientific Inc. (TMO)?
- The EV/Assets ratio for TMO stock is 1.98x.
- Is Thermo Fisher Scientific Inc.'s EV/Assets ratio high or low?
- Thermo Fisher Scientific Inc.'s EV/Assets ratio of 1.98x is 23% below its 5-year average of 2.57x, near the low end of its 5-year range (1.80x–3.93x).
- What is the TTM average EV/Assets ratio for Thermo Fisher Scientific Inc. (TMO)?
- The TTM average EV/Assets ratio for TMO stock is 2.16x.
- What is the 3Y average EV/Assets ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 3Y average EV/Assets ratio for TMO stock is 2.33x.
- What is the 5Y average EV/Assets ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 5Y average EV/Assets ratio for TMO stock is 2.57x.
- What is the 10Y average EV/Assets ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 10Y average EV/Assets ratio for TMO stock is 2.40x.
- What is the 15Y average EV/Assets ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 15Y average EV/Assets ratio for TMO stock is 2.04x.
- What is the 20Y average EV/Assets ratio for Thermo Fisher Scientific Inc. (TMO)?
- The 20Y average EV/Assets ratio for TMO stock is 1.82x.
Thermo Fisher Scientific Inc. EV/Assets Ratio History
| DATE | EV/ASSETS RATIO |
|---|---|
| 2026-06-09 | 1.98x |
| 2026-06-08 | 1.90x |
| 2026-06-05 | 1.91x |
| 2026-06-04 | 1.94x |
| 2026-06-03 | 1.91x |
| 2026-06-02 | 1.94x |
| 2026-06-01 | 1.98x |
| 2026-05-29 | 1.97x |
| 2026-05-28 | 1.96x |
| 2026-05-27 | 1.85x |
| 2026-05-26 | 1.83x |
| 2026-05-22 | 1.83x |
| 2026-05-21 | 1.83x |
| 2026-05-20 | 1.84x |
| 2026-05-19 | 1.83x |
| 2026-05-18 | 1.81x |
| 2026-05-15 | 1.80x |
| 2026-05-14 | 1.83x |
| 2026-05-13 | 1.82x |
| 2026-05-12 | 1.86x |
| 2026-05-11 | 1.84x |
| 2026-05-08 | 1.88x |
| 2026-05-07 | 1.91x |
| 2026-05-06 | 1.91x |
| 2026-05-05 | 1.89x |
| 2026-05-04 | 1.88x |
| 2026-05-01 | 1.90x |
| 2026-04-30 | 1.92x |
| 2026-04-29 | 1.87x |
| 2026-04-28 | 1.89x |
| 2026-04-27 | 1.88x |
| 2026-04-24 | 1.89x |
| 2026-04-23 | 1.88x |
| 2026-04-22 | 2.04x |
| 2026-04-21 | 2.07x |
| 2026-04-20 | 2.08x |
| 2026-04-17 | 2.08x |
| 2026-04-16 | 2.04x |
| 2026-04-15 | 2.10x |
| 2026-04-14 | 2.08x |
| 2026-04-13 | 2.04x |
| 2026-04-10 | 1.98x |
| 2026-04-09 | 1.99x |
| 2026-04-08 | 2.00x |
| 2026-04-07 | 1.95x |
| 2026-04-06 | 1.95x |
| 2026-04-02 | 1.96x |
| 2026-04-01 | 1.97x |
| 2026-03-31 | 1.96x |
| 2026-03-30 | 1.92x |
| 2026-03-27 | 1.90x |
| 2026-03-26 | 1.95x |
| 2026-03-25 | 1.96x |
| 2026-03-24 | 1.96x |
| 2026-03-23 | 1.91x |
| 2026-03-20 | 1.90x |
| 2026-03-19 | 1.89x |
| 2026-03-18 | 1.87x |
| 2026-03-17 | 1.90x |
| 2026-03-16 | 1.89x |
| 2026-03-13 | 1.87x |
| 2026-03-12 | 1.91x |
| 2026-03-11 | 1.97x |
| 2026-03-10 | 1.99x |
| 2026-03-09 | 2.02x |
| 2026-03-06 | 2.00x |
| 2026-03-05 | 2.05x |
| 2026-03-04 | 2.03x |
| 2026-03-03 | 2.02x |
| 2026-03-02 | 2.02x |
| 2026-02-27 | 2.06x |
| 2026-02-26 | 2.06x |
| 2026-02-25 | 2.21x |
| 2026-02-24 | 2.22x |
| 2026-02-23 | 2.22x |
| 2026-02-20 | 2.20x |
| 2026-02-19 | 2.22x |
| 2026-02-18 | 2.21x |
| 2026-02-17 | 2.17x |
| 2026-02-13 | 2.18x |
| 2026-02-12 | 2.20x |
| 2026-02-11 | 2.26x |
| 2026-02-10 | 2.31x |
| 2026-02-09 | 2.33x |
| 2026-02-06 | 2.32x |
| 2026-02-05 | 2.32x |
| 2026-02-04 | 2.40x |
| 2026-02-03 | 2.42x |
| 2026-02-02 | 2.46x |
| 2026-01-30 | 2.45x |
| 2026-01-29 | 2.50x |
| 2026-01-28 | 2.56x |
| 2026-01-27 | 2.62x |
| 2026-01-26 | 2.63x |
| 2026-01-23 | 2.62x |
| 2026-01-22 | 2.67x |
| 2026-01-21 | 2.66x |
| 2026-01-20 | 2.60x |
| 2026-01-16 | 2.60x |
| 2026-01-15 | 2.62x |
| 2026-01-14 | 2.61x |
| 2026-01-13 | 2.55x |
| 2026-01-12 | 2.59x |
| 2026-01-09 | 2.60x |
| 2026-01-08 | 2.55x |
| 2026-01-07 | 2.59x |
| 2026-01-06 | 2.60x |
| 2026-01-05 | 2.57x |
| 2026-01-02 | 2.50x |
| 2025-12-31 | 2.45x |
| 2025-12-30 | 2.47x |
| 2025-12-29 | 2.47x |
| 2025-12-26 | 2.46x |
| 2025-12-24 | 2.45x |
| 2025-12-23 | 2.46x |
| 2025-12-22 | 2.44x |
| 2025-12-19 | 2.41x |
| 2025-12-18 | 2.39x |
| 2025-12-17 | 2.39x |
| 2025-12-16 | 2.42x |
| 2025-12-15 | 2.44x |
| 2025-12-12 | 2.43x |
| 2025-12-11 | 2.45x |
| 2025-12-10 | 2.43x |
| 2025-12-09 | 2.39x |
| 2025-12-08 | 2.41x |
| 2025-12-05 | 2.43x |
| 2025-12-04 | 2.44x |
| 2025-12-03 | 2.46x |
| 2025-12-02 | 2.46x |
| 2025-12-01 | 2.47x |
| 2025-11-28 | 2.49x |
| 2025-11-26 | 2.50x |
| 2025-11-25 | 2.52x |
| 2025-11-24 | 2.48x |
| 2025-11-21 | 2.48x |
| 2025-11-20 | 2.43x |
| 2025-11-19 | 2.43x |
| 2025-11-18 | 2.44x |
| 2025-11-17 | 2.41x |
| 2025-11-14 | 2.45x |
| 2025-11-13 | 2.46x |
| 2025-11-12 | 2.48x |
| 2025-11-11 | 2.48x |
| 2025-11-10 | 2.44x |
| 2025-11-07 | 2.43x |
| 2025-11-06 | 2.40x |
| 2025-11-05 | 2.41x |
| 2025-11-04 | 2.40x |
| 2025-11-03 | 2.40x |
| 2025-10-31 | 2.41x |
| 2025-10-30 | 2.38x |
| 2025-10-29 | 2.39x |
| 2025-10-28 | 2.39x |
| 2025-10-27 | 2.41x |
| 2025-10-24 | 2.44x |
| 2025-10-23 | 2.44x |
| 2025-10-22 | 2.42x |
| 2025-10-21 | 2.39x |
| 2025-10-20 | 2.33x |
| 2025-10-17 | 2.32x |
| 2025-10-16 | 2.31x |
| 2025-10-15 | 2.27x |
| 2025-10-14 | 2.27x |
| 2025-10-13 | 2.26x |
| 2025-10-10 | 2.26x |
| 2025-10-09 | 2.30x |
| 2025-10-08 | 2.30x |
| 2025-10-07 | 2.32x |
| 2025-10-06 | 2.33x |
| 2025-10-03 | 2.33x |
| 2025-10-02 | 2.26x |
| 2025-10-01 | 2.28x |
| 2025-09-30 | 2.11x |
| 2025-09-29 | 2.03x |
| 2025-09-26 | 2.04x |
| 2025-09-25 | 2.02x |
| 2025-09-24 | 2.05x |
| 2025-09-23 | 2.06x |
| 2025-09-22 | 2.08x |
| 2025-09-19 | 2.09x |
| 2025-09-18 | 2.10x |
| 2025-09-17 | 2.07x |
| 2025-09-16 | 2.10x |
| 2025-09-15 | 2.07x |
| 2025-09-12 | 2.09x |
| 2025-09-11 | 2.14x |
| 2025-09-10 | 2.08x |
| 2025-09-09 | 2.10x |
| 2025-09-08 | 2.12x |
| 2025-09-05 | 2.14x |
| 2025-09-04 | 2.13x |
| 2025-09-03 | 2.11x |
| 2025-09-02 | 2.12x |
| 2025-08-29 | 2.14x |
| 2025-08-28 | 2.13x |
| 2025-08-27 | 2.13x |
| 2025-08-26 | 2.13x |
| 2025-08-25 | 2.14x |
| 2025-08-22 | 2.17x |
| 2025-08-21 | 2.11x |
| 2025-08-20 | 2.15x |
| 2025-08-19 | 2.16x |
| 2025-08-18 | 2.12x |
| 2025-08-15 | 2.13x |
| 2025-08-14 | 2.11x |
| 2025-08-13 | 2.11x |
| 2025-08-12 | 2.09x |
| 2025-08-11 | 2.03x |
| 2025-08-08 | 2.02x |
| 2025-08-07 | 2.00x |
| 2025-08-06 | 1.98x |
| 2025-08-05 | 2.04x |
| 2025-08-04 | 2.04x |
| 2025-08-01 | 2.03x |
| 2025-07-31 | 2.09x |
| 2025-07-30 | 2.13x |
| 2025-07-29 | 2.15x |
| 2025-07-28 | 2.16x |
| 2025-07-25 | 2.13x |
| 2025-07-24 | 2.12x |
| 2025-07-23 | 2.09x |
| 2025-07-22 | 1.94x |
| 2025-07-21 | 1.85x |
| 2025-07-18 | 1.89x |
| 2025-07-17 | 1.93x |
| 2025-07-16 | 1.90x |
| 2025-07-15 | 1.90x |
| 2025-07-14 | 1.93x |
| 2025-07-11 | 1.97x |
| 2025-07-10 | 1.95x |
| 2025-07-09 | 1.91x |
| 2025-07-08 | 1.93x |
| 2025-07-07 | 1.91x |
| 2025-07-03 | 1.95x |
| 2025-07-02 | 1.94x |
| 2025-07-01 | 1.92x |
| 2025-06-30 | 1.86x |
| 2025-06-27 | 1.87x |
| 2025-06-26 | 1.88x |
| 2025-06-25 | 1.87x |
| 2025-06-24 | 1.85x |
| 2025-06-23 | 1.83x |
| 2025-06-20 | 1.83x |
| 2025-06-18 | 1.81x |
| 2025-06-17 | 1.80x |
| 2025-06-16 | 1.85x |
| 2025-06-13 | 1.84x |
| 2025-06-12 | 1.89x |
| 2025-06-11 | 1.89x |
| 2025-06-10 | 1.89x |
| 2025-06-09 | 1.87x |
| 2025-06-06 | 1.84x |
| 2025-06-05 | 1.83x |
| 2025-06-04 | 1.85x |
| 2025-06-03 | 1.83x |
| 2025-06-02 | 1.82x |
| 2025-05-30 | 1.84x |
| 2025-05-29 | 1.85x |
| 2025-05-28 | 1.84x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Marc N. Casper